FP7Индивидуална стипендия2011–2013

ORGANO-CAS CAT · ORGANO-CASCADE CATALYSIS: A SHORTCUT TO STEREOCHEMICAL AND MOLECULAR COMPLEXITY

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2011-04-25 → 2013-04-24
Финансиране от ЕС
174 381 €
Участници
1
Схема
MC-IIF

Линиите свързват координатора с партньорите.

Накратко на български

Органокасказният катализ позволява бързото създаване на сложни молекули от прости вещества, например чрез синтез на хетероциклни съединения. Този метод спестява енергия и ресурси, което го прави подходящ за създаването на природни продукти и лекарствени вещества.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Organo-cascade Catalysis: A Shortcut to Stereochemical and Molecular Complexity

The emerging field of aminocatalytic cascade reactions provides a way of achieving stereochemical and molecular complexity while addressing the requests for atom and step economy or protecting-group-free synthesis. The synthetic potential of this bio-inspired approach has been validated by recent applications of asymmetric aminocascade reactions to the total synthesis of natural products. These studies support the idea that this cost-effective, energy-saving and sustainable synthetic strategy could become a reliable and versatile tool for modern asymmetric synthesis. In the ORGANO-CAS CAT project, we further innovated around the development of novel organocascade strategies for rapidly converting simple achiral starting materials into complex compounds embodying features of natural molecules. Since the vast majority of natural products and drug-like compounds possess heterocyclic moieties, we focused more on preparing diverse heterocyclic compounds, such as spirocyclic oxindole or benzofuranone derivatives. We recognised as a necessary step the identification of novel reactivity concepts to enable the inclusion of unprecedented transformations into elabourate yet experimentally simple organocascade reactions. During our research process, we produced research results of high quality and subsequently published them in top international journals and conferences: 1. We developed the first asymmetric organocatalytic Diels-Alder reaction of in situ generated heterocyclic ortho-quinodimethanes (oQDMs), reactive diene species that have never before succumbed to a catalytic approach. Asymmetric aminocatalysis, that uses chiral amines as catalysts, is the enabling strategy to induce the transient generation of indole-, pyrrole- or furan-based oQDMs from simple starting materials, while directing the pericyclic reactions with methyleneindolinones toward a highly stereoselective pathway. The approach provides straightforward access to construct a spirocyclic oxindole core with high chemical yield and excellent stereoselectivity (isolated yield 53 - 98 %, dr 8:1 -> 20:1, ee 94 -> 99 %). The reported strategy is conceptually original for asymmetric catalysis and we feel that the combination of novelty, high levels of yield and stereoselectivity, and application to indole-, pyrrole- or furan-based heterocyclic compounds using mild and simple reaction conditions will provide for the rapid application of this chemistry in synthetic and medicinal arenas. In addition, expanding upon the recently developed aminocatalytic asymmetric indole-2,3-quinodimethane strategy, a straightforward synthesis of complex molecules has been devised. We have shown how its potential can be expanded to include a variety of different dienophiles to access a straightforward synthesis of structurally and stereochemically complex tetrahydrocarbazoles. The chemistry's complexity-generating power was further harnessed by designing a multicatalytic, one-pot Diels-Alder/benzoin reaction sequence to stereoselectively access trans-fused tetracyclic indole-based compounds having four stereogenic centres with very high fidelity. 2.We then focused on the possibility of productively merging the iminium ion strategy with the concept of vinylogy. The resulting aminocatalytic activation mode, termed vinylogous iminium ion catalysis, contributes a strategy to forge a stereocentre at the remote carbonyl d-position, a synthetically difficult issue for which few catalytic solutions are known. When a cinchona-based primary amine condenses with ß-substituted cyclic dienones, an iminium ion intermediate of extended conjugation is formed, the electrophilicity of the d-carbon atom of this intermediate is higher than that of the cyclic dienone substrate. This aminocatalytic activation mode was highly stereoselective and displayed high selectivity for reaction at the d position. 3. We finally tried to address a significant limitation of asymmetric catalysis in that, when applied to processes that generate chiral molecules with multiple stereogenic centres in one single step, researchers cannot selectively access the full matrix of all possible stereoisomeric products. Mirror imaged products (complementary enantioselectivity) can be discretely provided by the enantiomeric pair of a chiral catalyst. But modulating the enforced sense of diastereoselectivity (control over the relative stereochemistry) using a single catalyst is an unmet challenge in asymmetric catalytic synthesis. We have found an innovative solution by programming the catalytic functions of a single chiral small-molecule organic catalyst (J. Am. Chem. Soc. 2011, 133, 17934 - 17941). Applying an external chemical stimulus, it was possible to arbitrarily induce stereodivergent pathways. The strategy has been used to fully control the stereochemical outcome of the asymmetric conjugate addition of alkyl thiols to a challenging class of Michael acceptors (a-substituted a,ß-unsaturated ketones, which have never served before as Michael acceptors of catalytic asymmetric reactions), a transformation which generates two adjacent stereocentres through an addition-protonation tandem sequence. The judicious choice of acidic additives and reaction media switches the sense of the catalyst's diastereoselection, thereby affording either the syn or anti product with high enantioselectivity. Due to its innovative aspect, our chemistry has been highlighted in Science (2011) 334, 570.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

To impact science and society in the way that we feel is possible, synthetic chemistry needs to combine innovation and execution. We are motivated by the idea that novel chemical methodologies are needed to enable the synthesis of novel, previously elusive natural-like scaffolds. Only innovative organic chemistry research can provide the next generation of problem solvers.The goal of the ORGANO-CAS CAT research project proposed here is to exploit the potential of Asymmetric Organocatalysis (which involves only organic elements in the active principle) to find cost-effective, environmentally benign, and sustainable synthetic methods for reproducing the rich structural diversity and complexity of natural molecules. This is in line with the European approach of attaining Sustainable Chemistry (SusChem).Recently, we demonstrated the potential of organocascade catalysis to recreate the intricate structural scaffold and related complex stereochemistry of natural-like compounds with very high fidelity. We want to further innovate around the development of novel organocascade strategies for rapidly converting simple achiral starting materials into complex compounds embodying features of natural molecules. We recognized as a necessary step the identification of novel reactivity concepts to enable the inclusion of unprecedented transformations into elaborate yet experimentally simple organocascade reactions. Specifically we will focus on the development of organocatalytic cascade reaction driven by dynamic kinetic resolution as well as on the inclusion of dienamine activation step within the cascade sequence. In the longer term, organocascade catalysis could become the ideal synthetic starting point for assembling libraries comprising enantiopure molecules, which will increase the probability of success in identifying drug-candidate structures

Оригинален текст от CORDIS (на английски).

Участници

  • FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA · TARRAGONAКоординаторИспания

Връзки

Данни: CORDIS, © Европейски съюз